scholarly journals The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore

2007 ◽  
Vol 14 (11) ◽  
pp. 751-766 ◽  
Author(s):  
L. F. Lacey ◽  
E. Gane
Keyword(s):  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis B ◽  
Antiviral Therapy ◽  
Chronic Hepatitis B ◽  
The Cost ◽  
Negative Chronic Hepatitis

Long-Term Results of Interferon Alpha Monotherapy in Patients with HBeAg-Negative Chronic Hepatitis B

2007 ◽  
Vol 52 (3) ◽  
pp. 727-731 ◽  
Author(s):  
Sabahattin Kaymakoglu ◽  
Ahmet Danalioglu ◽  
Kadir Demir ◽  
Cetin Karaca ◽  
Filiz Akyuz ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Interferon Alpha ◽  
Long Term Results ◽  
Negative Chronic Hepatitis

Antiviral Therapy for the Prevention of Long-Term Cirrhosis Risk in Patients with Chronic Hepatitis B

2016 ◽  
Vol 64 (2) ◽  
pp. S591
Author(s):  
H.-I. Yang ◽  
J. Hoang ◽  
D. Lin ◽  
J. Liu ◽  
H.-H. Hu ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Antiviral Therapy ◽  
Chronic Hepatitis B

Correction: DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long‑term therapy before HBsAg loss in non-cirrhotic HBeAg‑negative chronic hepatitis B

2018 ◽  
Vol 23 (8) ◽  
pp. 711
Author(s):  
George V Papatheodoridis ◽  
Eirini I Rigopoulou ◽  
Margarita Papatheodoridi ◽  
Kalliopi Zachou ◽  
Vassilios Xourafas ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Tenofovir Disoproxil Fumarate ◽  
Term Therapy ◽  
Hbsag Loss ◽  
Long Term Therapy ◽  
Negative Chronic Hepatitis
Sign in / Sign up

Export Citation Format

Share Document